| Type |
Details |
Score |
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
796
 |
| Fragment?: |
true |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
1528
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Publication |
| First Author: |
ElAli A |
| Year: |
2010 |
| Journal: |
Sci Signal |
| Title: |
Apolipoprotein E controls ATP-binding cassette transporters in the ischemic brain. |
| Volume: |
3 |
| Issue: |
142 |
| Pages: |
ra72 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Terekhanova NV |
| Year: |
2023 |
| Journal: |
Nature |
| Title: |
Epigenetic regulation during cancer transitions across 11 tumour types. |
| Volume: |
623 |
| Issue: |
7986 |
| Pages: |
432-441 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
F?l?p K |
| Year: |
2011 |
| Journal: |
Biochem Biophys Res Commun |
| Title: |
ABCC6 does not transport vitamin K3-glutathione conjugate from the liver: relevance to pathomechanisms of pseudoxanthoma elasticum. |
| Volume: |
415 |
| Issue: |
3 |
| Pages: |
468-71 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Puris E |
| Year: |
2024 |
| Journal: |
Front Pharmacol |
| Title: |
Sex-specific changes in protein expression of membrane transporters in the brain cortex of 5xFAD mouse model of Alzheimer's disease. |
| Volume: |
15 |
|
| Pages: |
1365051 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Meszaros P |
| Year: |
2013 |
| Journal: |
Biochim Biophys Acta |
| Title: |
The function of the ATP-binding cassette (ABC) transporter ABCB1 is not susceptible to actin disruption. |
| Volume: |
1828 |
| Issue: |
2 |
| Pages: |
340-51 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Ihlefeld K |
| Year: |
2015 |
| Journal: |
J Lipid Res |
| Title: |
Upregulation of ABC transporters contributes to chemoresistance of sphingosine 1-phosphate lyase-deficient fibroblasts. |
| Volume: |
56 |
| Issue: |
1 |
| Pages: |
60-9 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Muppidi JR |
| Year: |
2014 |
| Journal: |
Nature |
| Title: |
Loss of signalling via G?13 in germinal centre B-cell-derived lymphoma. |
| Volume: |
516 |
| Issue: |
7530 |
| Pages: |
254-8 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Lu E |
| Year: |
2019 |
| Journal: |
Nature |
| Title: |
S-Geranylgeranyl-L-glutathione is a ligand for human B cell-confinement receptor P2RY8. |
| Volume: |
567 |
| Issue: |
7747 |
| Pages: |
244-248 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Bogdanov YD |
| Year: |
1997 |
| Journal: |
J Biol Chem |
| Title: |
Early expression of a novel nucleotide receptor in the neural plate of Xenopus embryos. |
| Volume: |
272 |
| Issue: |
19 |
| Pages: |
12583-90 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Cantagrel V |
| Year: |
2004 |
| Journal: |
J Med Genet |
| Title: |
Disruption of a new X linked gene highly expressed in brain in a family with two mentally retarded males. |
| Volume: |
41 |
| Issue: |
10 |
| Pages: |
736-42 |
|
•
•
•
•
•
|
| Protein Domain |
| Type: |
Family |
| Description: |
This entry represents the P2Y8 receptor. It was originally identified in Xenopus and found to be activated equipotently by all naturally occurring nucleoside triphosphates (ATP, CTP, GTP, ITP and UTP) but not by inorganic polyphosphates [].P2RY8 is a G protein-coupled receptor for S-geranylgeranyl-glutathione (GGG), an endogenous metabolite present in lymphoid tissues. It couples the binding of GGG to the activation of GNA13 and downstream repression of AKT activation in lymphocytes defining their positioning and growth within lymphoid organs [, , ]. In lymphoid follicles, confines B cells and follicular helper T cells in germinal centers (GCs) in response to GGG local gradients established by GGT5 (via GGG catabolism) and ABCC1 (via extracellular transport) with lower concentrations of GGG found in the follicular dendritic cell network region around which germinal centers are formed [, , ]. In the bone marrow, also in response to GGG gradients established by GGT5 and ABCC1, it restricts chemotactic transmigration of B cells, T cells and NK cells from blood vessels to the bone marrow parenchyma [, ].There are three distinct families of extracellular receptors for purine and pyrimidine nucleotides [], known as P1, P2X and P2Y purinoceptors []. These receptors induce a wide variety of biological effects and are involved in many different cellular functions [, , ]. P2X receptors are ligand-gated ion channels, whereas P1 and P2Y receptors are rhodopsin-like G protein-coupled receptors [, ]. The families also differ by their method of activation: P1 receptors are preferentially activated by adenosine [], P2X via ATP [], whereas the P2Y receptors, in addition to being activated by ATP, are activated by different adenine and/or uridine nucleoside di- and triphosphates (ADP, UDP, UTP, UDP and UDP-glucose) [].The P2Y purinoceptors currently consist of eleven subtypes: P2Y1, P2Y2, P2Y3 P2Y4, P2Y6, P2Y8, P2Y10, P2Y11, P2Y12, P2Y13 and P2Y14 [, , ]. P2Y3 has, as yet, only been found in birds [], whilst the rest have been cloned in humans. The gaps in P2Y receptor numbering are due to the reclassification of some receptors that were initially associated with to the P2Y family. These include P2Y5 (now known as lysophosphatidic acid receptor 6), P2Y7 (now leukotriene B4 receptor) and P2Y9 (lysophosphatidic acid receptor 4) [, , , ]. |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Van Rhee AM |
| Year: |
1995 |
| Journal: |
Drug Des Discov |
| Title: |
Modelling the P2Y purinoceptor using rhodopsin as template. |
| Volume: |
13 |
| Issue: |
2 |
| Pages: |
133-54 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
von K?gelgen I |
| Year: |
2000 |
| Journal: |
Naunyn Schmiedebergs Arch Pharmacol |
| Title: |
Molecular pharmacology of P2Y-receptors. |
| Volume: |
362 |
| Issue: |
4-5 |
| Pages: |
310-23 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Fern?ndez O |
| Year: |
2000 |
| Journal: |
Pharmacology |
| Title: |
Renal vascular reactivity to P(2)-purinoceptor activation in spontaneously hypertensive rats. |
| Volume: |
60 |
| Issue: |
1 |
| Pages: |
47-50 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Marques-da-Silva C |
| Year: |
2011 |
| Journal: |
Immunobiology |
| Title: |
Purinergic receptor agonists modulate phagocytosis and clearance of apoptotic cells in macrophages. |
| Volume: |
216 |
| Issue: |
1-2 |
| Pages: |
1-11 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Ferrari D |
| Year: |
2000 |
| Journal: |
FASEB J |
| Title: |
The P2 purinergic receptors of human dendritic cells: identification and coupling to cytokine release. |
| Volume: |
14 |
| Issue: |
15 |
| Pages: |
2466-76 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Bulanova E |
| Year: |
2010 |
| Journal: |
Purinergic Signal |
| Title: |
P2 receptor-mediated signaling in mast cell biology. |
| Volume: |
6 |
| Issue: |
1 |
| Pages: |
3-17 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Fredholm BB |
| Year: |
2001 |
| Journal: |
Pharmacol Rev |
| Title: |
International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. |
| Volume: |
53 |
| Issue: |
4 |
| Pages: |
527-52 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
von K?gelgen I |
| Year: |
2006 |
| Journal: |
Pharmacol Ther |
| Title: |
Pharmacological profiles of cloned mammalian P2Y-receptor subtypes. |
| Volume: |
110 |
| Issue: |
3 |
| Pages: |
415-32 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Burnstock G |
| Year: |
1997 |
| Journal: |
Neuropharmacology |
| Title: |
The past, present and future of purine nucleotides as signalling molecules. |
| Volume: |
36 |
| Issue: |
9 |
| Pages: |
1127-39 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Abbracchio MP |
| Year: |
1994 |
| Journal: |
Pharmacol Ther |
| Title: |
Purinoceptors: are there families of P2X and P2Y purinoceptors? |
| Volume: |
64 |
| Issue: |
3 |
| Pages: |
445-75 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Abbracchio MP |
| Year: |
2006 |
| Journal: |
Pharmacol Rev |
| Title: |
International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy. |
| Volume: |
58 |
| Issue: |
3 |
| Pages: |
281-341 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Webb TE |
| Year: |
1993 |
| Journal: |
FEBS Lett |
| Title: |
Cloning and functional expression of a brain G-protein-coupled ATP receptor. |
| Volume: |
324 |
| Issue: |
2 |
| Pages: |
219-25 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Yanagida K |
| Year: |
2009 |
| Journal: |
J Biol Chem |
| Title: |
Identification and characterization of a novel lysophosphatidic acid receptor, p2y5/LPA6. |
| Volume: |
284 |
| Issue: |
26 |
| Pages: |
17731-41 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Owman C |
| Year: |
1996 |
| Journal: |
Genomics |
| Title: |
Cloning of cDNA encoding a putative chemoattractant receptor. |
| Volume: |
37 |
| Issue: |
2 |
| Pages: |
187-94 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Akbar GK |
| Year: |
1996 |
| Journal: |
J Biol Chem |
| Title: |
Molecular cloning of a novel P2 purinoceptor from human erythroleukemia cells. |
| Volume: |
271 |
| Issue: |
31 |
| Pages: |
18363-7 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Noguchi K |
| Year: |
2003 |
| Journal: |
J Biol Chem |
| Title: |
Identification of p2y9/GPR23 as a novel G protein-coupled receptor for lysophosphatidic acid, structurally distant from the Edg family. |
| Volume: |
278 |
| Issue: |
28 |
| Pages: |
25600-6 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Van Kolen K |
| Year: |
2006 |
| Journal: |
Purinergic Signal |
| Title: |
Integration of P2Y receptor-activated signal transduction pathways in G protein-dependent signalling networks. |
| Volume: |
2 |
| Issue: |
3 |
| Pages: |
451-69 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Ralevic V |
| Year: |
1998 |
| Journal: |
Pharmacol Rev |
| Title: |
Receptors for purines and pyrimidines. |
| Volume: |
50 |
| Issue: |
3 |
| Pages: |
413-92 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Gachet C |
| Year: |
2001 |
| Journal: |
Int J Hematol |
| Title: |
Identification, characterization, and inhibition of the platelet ADP receptors. |
| Volume: |
74 |
| Issue: |
4 |
| Pages: |
375-81 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Montiel M |
| Year: |
2006 |
| Journal: |
Cell Physiol Biochem |
| Title: |
P2Y receptors activate MAPK/ERK through a pathway involving PI3K/PDK1/PKC-zeta in human vein endothelial cells. |
| Volume: |
18 |
| Issue: |
1-3 |
| Pages: |
123-34 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Wood JD |
| Year: |
2006 |
| Journal: |
Curr Opin Pharmacol |
| Title: |
The enteric purinergic P2Y1 receptor. |
| Volume: |
6 |
| Issue: |
6 |
| Pages: |
564-70 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Adrian K |
| Year: |
2000 |
| Journal: |
Biochim Biophys Acta |
| Title: |
Expression of purinergic receptors (ionotropic P2X1-7 and metabotropic P2Y1-11) during myeloid differentiation of HL60 cells. |
| Volume: |
1492 |
| Issue: |
1 |
| Pages: |
127-38 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
North RA |
| Year: |
2002 |
| Journal: |
Physiol Rev |
| Title: |
Molecular physiology of P2X receptors. |
| Volume: |
82 |
| Issue: |
4 |
| Pages: |
1013-67 |
|
•
•
•
•
•
|